Then, we found non-inherited HHcy patients were not trouble with cognitive impairment, but the serum homocysteine and acylcarnitine biomarkers of non-inherited HHcy patients had similar elevated trends with cblC-MMA patients. This evidence concerns the gene CBLC and Cognitive impairment.